The impacts of COVID-19 measures on drug markets and drug use among a cohort of people who use methamphetamine in Victoria, Australia.

Rathnayake K, Agius PA, Ward B, Hickman M, Maher L, Stoové M, Doyle JS, Hellard M, Wilkinson A, Quinn B, Crawford S, Sutton K, Dietze P

COVID-19

Is use of opioid agonist treatment associated with broader primary healthcare use among men with recent injecting drug use histories following release from prison? A prospective cohort study.

Curtis M, Wilkinson AL, Dietze P, Stewart AC, Kinner SA, Winter RJ, Aitken C, Walker SJ, Cossar RD, Butler T, Stoové M

Prevalence and Correlates of Panic Attacks Among People Who Primarily Smoke Methamphetamine

Hine R, Ward B, Kippen R, Sutton K, Duncan Z, Quinn B, Powell A, Dietze P

Alcohol and Other Drugs

Incidence of suicide and self-harm among people with opioid use disorder and the impact of opioid agonist treatment: A retrospective data linkage study.

Colledge-Frisby S, Jones N, Degenhardt L, Hickman M, Padmanathan P, Santo T, Farrell M, Gisev N

Alcohol and Other Drugs

COVID-19 vaccine attitudes and facilitators among people in Australia who inject drugs.

Price O, Maher L, Dietze PM, Bruno R, Crawford S, Sutherland R, Salom C, Dore GJ, Peacock A

COVID-19

Disruption to Australian heroin, methamphetamine, cocaine and ecstasy markets with the COVID-19 pandemic and associated restrictions.

Price O, Man N, Sutherland R, Bruno R, Dietze P, Salom C, Agramunt S, Grigg J, Degenhardt L, Peacock A

Alcohol and Other Drugs COVID-19 Injecting Drug Use